Stock CFRXQ CONTRAFECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. ContraFect Corporation

Equities

CFRXQ

US2123264093

Delayed OTC Markets
Other stock markets
 12:35:44 2024-04-24 pm EDT 		5-day change 1st Jan Change
0.018 USD -5.66% Intraday chart for ContraFect Corporation -16.67% -40.00%
Apr. 19 North American Morning Briefing : Stock Futures -2- DJ
Apr. 12 North American Morning Briefing : Big Banks Kick -2- DJ

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
North American Morning Briefing : Stocks Futures Steady on Rates Optimism
DJ
Maxim Upgrades ContraFect to Buy From Hold, Price Target is $3
MT
Maxim Downgrades ContraFect to Hold From Buy
MT
SVB Securities Downgrades ContraFect to Market Perform From Outperform, Lowers Price Target to $1 From $9
MT
Cantor Fitzgerald Downgrades ContraFect to Neutral From Overweight, Adjusts Price Target to $1 From $15
MT
WBB Securities Upgrades ContraFect to Strong Buy from Buy, Sets $7 Price Target
MT
SVB Leerink Adjusts ContraFect's Price Target to $9 from $14, Maintains Outperform Rating
MT
WBB Securities Upgrades ContraFect to Buy from Speculative Buy, Sets $6.50 Price Target
MT
CONTRAFECT : SVB Leerink Starts ContraFect at Outperform with $14 Price Target
MT
CONTRAFECT : Chardan Suspends Coverage on ContraFect at Buy Rating With $17.50 Price Target
MT
CONTRAFECT : Mizuho Adjusts ContraFect's Price Target to $10 From $12, Maintains Buy Rating
MT
CONTRAFECT : WBB Securities Initiates Coverage on ContraFect With Speculative Buy Rating, $6.50 Price Target
MT
CONTRAFECT : Chardan Adjusts ContraFect's Price Target to $17.50 from $15, Keeps Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CFRXQ Stock
  4. News ContraFect Corporation
  5. Analyst Reco.